R Launois

2.0k total citations
76 papers, 1.4k citations indexed

About

R Launois is a scholar working on Economics and Econometrics, Surgery and General Health Professions. According to data from OpenAlex, R Launois has authored 76 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Economics and Econometrics, 19 papers in Surgery and 12 papers in General Health Professions. Recurrent topics in R Launois's work include Health Systems, Economic Evaluations, Quality of Life (23 papers), Diagnosis and Treatment of Venous Diseases (9 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). R Launois is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (23 papers), Diagnosis and Treatment of Venous Diseases (9 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). R Launois collaborates with scholars based in France, Belgium and United Kingdom. R Launois's co-authors include Jeanne Reboul‐Marty, Bernadette Henry, Armando Mansilha, Georges Jantet, K Le Lay, Jacques Bonneterre, Bertrand Guidet, Philippe Aegerter, Lionel Riou França and Yvon Merlière and has published in prestigious journals such as Stroke, Gut and Social Science & Medicine.

In The Last Decade

R Launois

71 papers receiving 1.3k citations

Peers

Countries citing papers authored by R Launois

Since Specialization

Citations

This map shows the geographic impact of R Launois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Launois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Launois more than expected).

Fields of papers citing papers by R Launois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Launois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Launois. The network helps show where R Launois may publish in the future.

Co-authorship network of co-authors of R Launois

This figure shows the co-authorship network connecting the top 25 collaborators of R Launois. A scholar is included among the top collaborators of R Launois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Launois. R Launois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost comparison of four venous catheters: Short peripheral catheter, Long peripheral line, Midline, and PICC for peripheral infusion 2024 ·The Journal of Vascular Access ·(unknown), (unknown), (unknown), F. Espinasse, (unknown), Mostafa El Hajjam, (unknown), R Launois	2
2	Barriers and Expectations for Patients in Post-Osteoporotic Fracture Care in France: The EFFEL Study 2021 ·Value in Health ·R Launois, (unknown), Daniel Benamouzig, (unknown), Karine Briot, Françoise Alliot, (unknown), Laurent Grange, (unknown), Chantal Touboul, Jean-Michel Joubert, Christian Roux	6
3	Cost Effectiveness of Emollients in the Prevention of Relapses in Atopic Dermatitis 2020 ·Clinical Cosmetic and Investigational Dermatology ·(unknown), (unknown), R Launois, (unknown), C. Taïeb, Sophie Seité	4
4	Real-world care for individuals aged over fifty with fractures in France: Evidence for a wide care gap–The EPIFRACT Study 2020 ·Joint Bone Spine ·Karine Briot, Laurent Grange, Bernard Cortet, Jean-Marc Féron, Pierre Chauvin, (unknown), (unknown), (unknown), Chantal Touboul, (unknown), Jean-Michel Joubert, R Launois	5
5	PMU27 BUDGET IMPACT ANALYSIS OF IMPLEMENTING THE CLOSED-SYSTEM TRANSFER DEVICE QIMONO® DURING CHEMOTHERAPY ADMINISTRATION IN A FRENCH HOSPITAL 2019 ·Value in Health ·(unknown), (unknown), (unknown), R Launois	1
6	Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France 2016 ·Therapeutic Advances in Gastroenterology ·Anastasiia Kabeshova, (unknown), (unknown), Robert Benamouzig, R Launois	12
7	Évaluation quasi-expérimentale des interventions médicales : méthode des variables instrumentales 2015 ·Salah Ghabri, R Launois	1
8	Psychometric Validation of the 14 items ChronIc Venous Insufficiency Quality of Life Questionnaire (CIVIQ-14): Confirmatory Factor Analysis 2015 ·European Journal of Vascular and Endovascular Surgery ·(unknown), (unknown), Kenneth Katumba, R Launois	16
9	Health-related quality-of-life scales specific for chronic venous disorders of the lower limbs 2014 ·Journal of Vascular Surgery Venous and Lymphatic Disorders ·R Launois	36
10	Structural Validation of the Chronic Venous Insufficiency Quality of Life Questionnaire-14 (CIVIQ-14) : A Confirmatory Factor Analysis 2013 ·Value in Health ·(unknown), Kenneth Katumba, R Launois	1
11	PMS88 Mixed Treatment Comparison, Cost-Effectiveness Analysis and Budget Impact Model in the Treatment of Rheumatoid Arthritis After Failure of Conventional Dmard Therapy Using Comprehensive Bayesian Decision Analytical Modelling 2012 ·Value in Health ·R Launois, (unknown), (unknown)	0
12	Construction and international validation of CIVIQ-14 (a short form of CIVIQ-20), a new questionnaire with a stable factorial structure 2011 ·Quality of Life Research ·R Launois, (unknown), Francisco S. Lozano, Armando Mansilha	47
13	An Economic Evaluation of Cetuximab Combined with Radiotherapy for Patients with Locally Advanced Head and Neck Cancer in Belgium, France, Italy, Switzerland, and the United Kingdom 2008 ·Value in Health ·(unknown), Α. Διαμαντόπουλος, Jacques Bernier, Patrick Schöffski, K Hieke, LG Mantovani, R Launois, Ingolf Griebsch, Paul Robinson	51
14	Budget impact model of rituximab after failure of one or more TNFα inhibitor therapies in the treatment of rheumatoid arthritis 2008 ·Joint Bone Spine ·R Launois, (unknown), Nathalie Saidenberg-Kermanac’h, (unknown), Lionel Riou França, Marie‐Christophe Boissier	24
15	Pharmacoeconomic Positioning of Sertindole among Atypical Antipsychotics in the Management of Schizophrenia in Turkey 2007 ·SSRN Electronic Journal ·Karina Hansen, R Launois, Christophe Sapin	2
16	Internet pharmaco-economic studies in metastatic colorectal cancer 2001 ·Critical Reviews in Oncology/Hematology ·R Launois	1
17	Pooling public and private funds in the patient's interest: The case for long-term care insurance 1996 ·Social Science & Medicine ·R Launois	3
18	Construction and validation of a quality of life questionnaire in Chronic Lower Limb Venous Insufficiency (CIVIQ) 1996 ·Quality of Life Research ·R Launois, Jeanne Reboul‐Marty, Bernadette Henry	315
19	Décision thérapeutique et qualité de Vie 1992 ·R Launois, (unknown)	3
20	Les réseaux de soins, médecine de demain 1985 ·Economica eBooks ·Pierre Giraud, R Launois	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact